Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayesha Ishtiaq has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An integrated bioinformatics approach for identification of key modulators and biomarkers involved in atrial fibrillation

    by Summan Thahiem, Ayesha Ishtiaq, Faisal Iftekhar, Muhammad Ishtiaq Jan, Iram Murtaza

    Introduction: Atrial fibrillation (AFib) is a sustained form of cardiac arrythmia that occurs due to sympathetic overdrive, neurohumoral and electrophysiological changes. Sympatho-renal modulatory approach via miRNA-based therapeutics is likely to be an important treatment option for AFib. The study was aimed to unravel the common miRNAs as therapeutic targets involved in sympatho- renovascular axis to combat AFib. Methods: We employed the bioinformatics approach to discover differentially expressed genes (DEGs) from microarray gene expression datasets GSE41177 and GSE79768 of AFib patients. Concomitantly, genes associated with sympathetic cardio-renal axis, from Genetic Testing Registry (GTR) of National Center for Biotechnology Information (NCBI) were also analyzed. Overlapping miRNAs that target the maximum number of genes across all three pathological conditions perpetuating AFib were shortlisted. To confirm the reliability of the identified miRNAs, differential expression analysis was performed on miRNA expression profiles GSE190898, GSE68475, GSE70887 and GSE28954 derived from AFib patient samples. Results: ShinyGO analysis revealed enrichment in beta-adrenergic signaling, calcium signaling, as well as G protein-coupled receptor (GPCR) signaling involved in post synaptic membrane potential. The intersection of top 10 modules in miRNA-mRNA network revealed hub miRNAs having highest node degree, maximum neighborhood component (MNC), and maximal clique centrality (MCC) scores. Differential expression analysis revealed hub miRNAs identified through integrated approach were found to be significantly dysregulated in AFib patients. Conclusion: This integrated approach identified 6 hub miRNAs, 4 reported (miR-101-3p, miR-23-3p, miR-27-3p, miR-25-3p) and 2 novel (miR-32-5p, miR-92-3p) miRNAs that might act as putative biomarkers for AFib.

  • Global Impact and Strategies to Reduce the Mortality from Cardiovascular Diseases

    by Aqsa Naeem, Syed Hamid Abbas, Muhammad Yousaf, Ayesha Ishtiaq, Iram Murtaza


  • A cohort study investigating the role of Bisphenol A in the molecular pathogenesis of breast cancer

    by Ayesha Ishtiaq, Maryam Anyat Nasrullah, Jahangir Sarwar Khan, Sara Malik, Usman Tareen, Mariam Anees, Aneesa Sultan, Iram Murtaza

    Background Breast cancer is an abnormal division of breast cells. Bisphenol A (BPA), an environmental toxicant, is identified as an emerging risk factor for breast cancer development. However, to the best of our knowledge, no previous study has investigated the BPA levels in breast cancer patients in Pakistan. The present study sought to explore the role of BPA in tumor growth among the Pakistani population. Methods The levels of BPA were analyzed in the serum samples of breast cancer patients and controls by using HPLC. To elucidate the role of BPA to initiate tumorigenic events in breast tissue different biochemical assays along with expression analysis of tumor markers were performed. Results The level of BPA in the serum samples of breast cancer patients was significantly higher than control. Histological analysis of breast cancer tissue samples revealed distinct subtypes of tumor, such as ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). There was a significant increase in ROS level while a significant decrease in the levels of superoxide dismutase (SOD) and catalase (CAT) enzymes in malignant breast tissue samples as compared to control tissue samples. We found upregulated expression of p53, ZEB1 and WNT1 genes at mRNA level in malignant breast tissue samples by 17 folds, 328 folds and 35 folds, respectively. p53 protein expression in malignant breast tissue samples was also enhanced at the translational level. Conclusion Current findings suggest a relationship between BPA and the progression of breast cancer among the Pakistani population.


  • miRNAs as a Therapeutic Target for Vascular Dysfunction in Diabetes

    by Aqsa Naeem, Ayesha Ishtiaq, Iram Murtaza

  • Open Access

    N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators

    by Iram Mushtaq, Zainab Bashir, Mehvish Sarwar, Maria Arshad, Ayesha Ishtiaq, Wajiha Khan, Uzma Khan, Sobia Tabassum, Tahir Ali, Tahzeeb Fatima, et al.

    Metabolic disorders often lead to cardiac complications. Metabolic deregulations during diabetic conditions are linked to mitochondrial dysfunctions, which are the key contributing factors in cardiac hypertrophy. However, the underlying mechanisms involved in diabetes-induced cardiac hypertrophy are poorly understood. In the current study, we initially established a diabetic rat model by alloxan-administration, which was validated by peripheral glucose measurement. Diabetic rats displayed myocardial stiffness and fibrosis, changes in heart weight/body weight, heart weight/tibia length ratios, and enhanced size of myocytes, which altogether demonstrated the establishment of diabetic cardiac hypertrophy (DCH). Furthermore, we examined the expression of genes associated with mitochondrial signaling impairment. Our data show that the expression of PGC-1α, cytochrome c, MFN-2, and Drp-1 was deregulated. Mitochondrial-signaling impairment was further validated by redox-system dysregulation, which showed a significant increase in ROS and thiobarbituric acid reactive substances, both in serum and heart tissue, whereas the superoxide dismutase, catalase, and glutathione levels were decreased. Additionally, the expression levels of pro-apoptotic gene PUMA and stress marker GATA-4 genes were elevated, whereas ARC, PPARα, and Bcl-2 expression levels were decreased in the heart tissues of diabetic rats. Importantly, these alloxan-induced impairments were rescued by N-acetyl cysteine, ascorbic acid, and selenium treatment. This was demonstrated by the amelioration of myocardial stiffness, fibrosis, mitochondrial gene expression, lipid profile, restoration of myocyte size, reduced oxidative stress, and the activation of enzymes associated with antioxidant activities. Altogether, these data indicate that the improvement of mitochondrial dysfunction by protective agents such as N-acetyl cysteine, selenium, and ascorbic acid could rescue diabetes-associated cardiac complications, including DCH.


  • Cross talk of serum elements, cardiac and liver enzymes in patients with HCV chronic hepatitis and hepatocellular carcinoma in Pakistani population

    by Tabassum Naeem, Tahir Ali, Iram Mushtaq, Ayesha Ishtiaq, Iram Murtaza

    HCV-associated hepatic pathologies are now the frequent inducer of cardiac abnormalities because of cardio-hepatic interaction. Studies are going on to elucidate and highlight the possible factors involved in this complex interaction, but this paradigm is still unclear. Here, we aimed to explore the interrelationship among electrolytes, cardiac, and liver enzymes in HCV-associated hepatic abnormalities, including chronic hepatitis and hepatocellular carcinoma in the Pakistani population. 100 Hepatitis C virus (HCV) infected patients with liver disorders and 50 healthy individuals were recruited in the present analysis. Trace elements, ions, and enzyme concentrations were quantified via an automatic analyzer, while HCV was confirmed by enzyme-linked immunosorbent assay (ELISA). Our results demonstrated that serum Ca++, Mg++, Fe++, Cl-, and PO4- levels were significantly increased in HCV patients with hepatic pathologies, including cirrhosis and carcinoma. Cardiac enzymes, including aspartate aminotransferase (AST), creatine kinase (CK2), and lactate dehydrogenase (LDH) concentration, were also elevated in HCV patients. Furthermore, serum cholesterol and triglyceride levels significantly differed in HCV patients than in normal individuals. Impaired alkaline transaminase (ALT) and alkaline phosphatase levels in HCV patients further validate the HCV patients' hepatic pathologies. Interestingly, all these impaired factors were positively correlated with the progression of hepatic disorders. In conclusion, altered ionic concentrations, cardiac enzymes, and liver dysfunction markers suggest their significant relationship to HCV leading liver pathologies in the Pakistani population.